Ardelyx

Ardelyx

Develops novel oral therapeutics to treat mineral metabolism and metabolic disorders.

Launch date
Employees
Market cap
€1.4b
Enterprise valuation
€1.3b (Public information from Sep 2024)
Fremont California (HQ)
Authorizing premium user...